Antitrust Division may block depositions in Teva securities suit, court says
Shutterstock/Fahroni
A Connecticut federal judge has said the Department of Justice can intervene in private litigation against Teva Pharmaceuticals, accepting the Antitrust Division’s arguments that certain depositions and discovery could compromise the integrity of its investigation into price-fixing in the generic pharmaceuticals industry.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10